logo


FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:February 28, 2011
Estimated average burden
hours per response0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Cameron Kevin M
(Last)(First)(Middle)
669 RIVER DRIVE,, CENTER 2
(Street)
ELMWOOD PARKNJ07407
(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
HLTH CORP [HLTH]		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code
(Instr. 8)		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 10/23/2009 D  480,078 (1) D (2) 0 D  
Common Stock 10/23/2009 D  156 D (2) 0 I By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date
(Month/Day/Year)		7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) $ 17.5481 10/23/2009 D   325,000 10/23/200904/04/2010 Common Stock 325,000 (3) 0 D  
Stock Option (right to buy) $ 12.2125 10/23/2009 D   625,000 10/23/200904/04/2010 Common Stock 625,000 (4) 0 D  
Stock Option (right to buy) $ 11.55 10/23/2009 D   125,000 10/23/200906/05/2010 Common Stock 125,000 (5) 0 D  
Stock Option (right to buy) $ 12.75 10/23/2009 D   200,000 10/23/200908/21/2010 Common Stock 200,000 (6) 0 D  
Stock Option (right to buy) $ 3.43 10/23/2009 D   87,168 10/23/200909/20/2011 Common Stock 87,168 (7) 0 D  
Stock Option (right to buy) $ 8.59 10/23/2009 D   200,000 10/23/200903/17/2014 Common Stock 200,000 (8) 0 D  
Stock Option (right to buy) $ 6.99 10/23/2009 D   1,500,000 10/23/200910/01/2014 Common Stock 1,500,000 (9) 0 D  
Stock Option (right to buy) $ 11.86 10/23/2009 D   900,000 10/23/200910/23/2016 Common Stock 900,000 (10) 0 D  
Stock Option (right to buy) $ 9.46 10/23/2009 D   40,000  (11)12/10/2018 Common Stock 40,000 (12) 0 D  
Explanation of Responses:
1. Includes 120,000 shares of unvested Restricted Stock.
2. Pursuant to the terms of the merger agreement ("Merger Agreement") between HLTH Corporation ("HLTH") and WebMD Health Corp. ("WebMD") dated June 17, 2009, each share of HLTH common stock was automatically converted into .4444 shares of WebMD common stock on the effective date of the merger.
3. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 144,430 shares of WebMD common stock with an exercise price of $39.49 per share.
4. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 277,750 shares of WebMD common stock with an exercise price of $27.49 per share.
5. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 55,550 shares of WebMD common stock with an exercise price of $26.00 per share.
6. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 88,880 shares of WebMD common stock with an exercise price of $28.70 per share.
7. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 38,737 shares of WebMD common stock with an exercise price of $7.72 per share.
8. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 88,880 shares of WebMD common stock with an exercise price of $19.33 per share.
9. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 666,600 shares of WebMD common stock with an exercise price of $15.73 per share.
10. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 399,960 shares of WebMD common stock with an exercise price of $26.69 per share.
11. 25% of the shares underlying the option vested or are scheduled to vest on the first anniversary of the grant date and 1/48 of the shares vested or are scheduled to vest monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for each of these options was ten years prior to the expiration date.
12. Pursuant to the terms of the Merger Agreement, this stock option was automatically assumed by WebMD on the effective date of the merger and replaced with an option to purchase 17,776 shares of WebMD common stock with an exercise price of $21.29 per share.
/s/ Lewis H. Leicher, Attorney-in-Fact for Kevin M. Cameron10/26/2009
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Add to Delicious   Add to DeliciousDigg It  Digg It
Send Email Send by Email Send Email Post Comment

 
Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

copryright 2009 all rights reserved
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia